Literature DB >> 16148010

FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family.

Emile van den Akker1, Sabine Ano, Hsiu-Ming Shih, Ling-Chi Wang, Martine Pironin, Jorma J Palvimo, Noora Kotaja, Olivier Kirsh, Anne Dejean, Jacques Ghysdael.   

Abstract

FLI-1 is a transcription factor of the ETS family that is involved in several developmental processes and that becomes oncogenic when overexpressed or mutated. As the functional regulators of FLI-1 are largely unknown, we performed a yeast two-hybrid screen with FLI-1 and identified the SUMO E3 ligase PIASxalpha/ARIP3 as a novel in vitro and in vivo binding partner of FLI-1. This interaction involved the ETS domain of FLI-1 and required the integrity of the SAP domain of PIASxalpha/ARIP3. SUMO-1 and Ubc9, the ubiquitin carrier protein component in the sumoylation pathway, were also identified as interactors of FLI-1. Both PIASxalpha/ARIP3 and the closely related PIASxbeta isoform specifically enhanced sumoylation of FLI-1 at Lys(67), located in its N-terminal activation domain. PIASxalpha/ARIP3 relocalized the normally nuclear but diffusely distributed FLI-1 protein to PIASxalpha nuclear bodies and repressed FLI-1 transcriptional activation as assessed using different ETS-binding site-dependent promoters and different cell systems. PIASxalpha repressive activity was independent of sumoylation and did not result from inhibition of FLI-1 DNA-binding activity. Analysis of the properties of a series of ARIP3 mutants showed that the repressive properties of PIASxalpha/ARIP3 require its physical interaction with FLI-1, identifying PIASxalpha as a novel corepressor of FLI-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148010     DOI: 10.1074/jbc.M502938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.

Authors:  Joseph-Anthony T Tan; Jing Song; Yuan Chen; Linda K Durrin
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 2.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

Review 3.  Regulation of endothelial cell development by ETS transcription factors.

Authors:  Stryder M Meadows; Candace T Myers; Paul A Krieg
Journal:  Semin Cell Dev Biol       Date:  2011-09-18       Impact factor: 7.727

4.  Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Alfred C O Vertegaal; Zeinab Anvarian; Crina I A Balog; André M Deelder; Paul J Hensbergen; David A Baker
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

5.  Tollip is a mediator of protein sumoylation.

Authors:  Alessia Ciarrocchi; Romina D'Angelo; Chiara Cordiglieri; Ada Rispoli; Spartaco Santi; Massimo Riccio; Simona Carone; Anna Laura Mancia; Simone Paci; Elena Cipollini; Davide Ambrosetti; Marialuisa Melli
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

6.  Tissue-specific inhibition of protein sumoylation uncovers diverse SUMO functions during C. elegans vulval development.

Authors:  Aleksandra Fergin; Gabriel Boesch; Nadja R Greter; Simon Berger; Alex Hajnal
Journal:  PLoS Genet       Date:  2022-06-06       Impact factor: 6.020

7.  Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.

Authors:  Chongyang Li; Francis P McManus; Cédric Plutoni; Cristina Mirela Pascariu; Trent Nelson; Lara Elis Alberici Delsin; Gregory Emery; Pierre Thibault
Journal:  Nat Commun       Date:  2020-02-11       Impact factor: 14.919

8.  SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.

Authors:  Nanyang Yang; Sitong Liu; Tian Qin; Xintong Liu; Nobumoto Watanabe; Kevin H Mayo; Jiang Li; Xiaomeng Li
Journal:  Cell Commun Signal       Date:  2019-11-21       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.